References
- Peterson C, Grosse S, Rui L, et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. Am J Obstet Gynecol. 2005;75:1–9.
- Centers for Disease Control and Prevention. National diabetes statistics report 2017. Atlanta (GA): Central for Disease Control and Prevention. U.S. Department of Health and Human Services; 2017.
- The American College of Obstetrics and Gynecology. Pregestational diabetes mellitus. ACOG practice bulletin. Obstet Gynecol. 2018;132(6):e228–e248.
- American Diabetes Association: Preconception Care of Women with Diabetes. [cited 2019 Jan]. Available from: http://care.diabetesjournals.org/content/26/suppl_l/s91
- Roberts M, Lindheimer M, Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol. 1996;270:338–343.
- Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin The American College of Obstetrics and Gynecology. Obstet Gynecol. 2018;133(6):e237–260.
- Liu X. Classification accuracy and cut point selection. Stat Med. 2012;31(23):2676–2686.
- Jones D, Hayslett J. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4):226–232.
- How H, Sibai B, Lindheimer M, et al. Is early pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus? Am J Obstet Gynecol. 2004;190(3):775–778.
- Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. Am J Obstet Gynecol. 2000;182(2):364–369.